Newly implemented electronic laboratory notebook enables faster access to data and real-time data integrity from ongoing quality control throughout the bioanalytical workflow.
Hybrid ECG Core lab provides clients faster access to data, cost savings and higher quality of data.
–Celerion, the premier provider of innovative early stage clinical research solutions, and BryanLGH Health System, a locally owned, non-‐profit healthcare organization, announce an alliance to provide a dedicated wing at BryanLGH Medical Center West in Lincoln, Nebraska for early clinical studies including Phase I and First-‐In-‐Human.
The addition of the USP <797> Clean Room to Celerion’s Phase I core capabilities, enables sterile extemporaneous compounding in-house for microtracer studies. Clients benefit by accessing quality data earlier in drug development process.
Life sciences industry veteran Susan Thornton, Ph.D., leads privately-owned contract research organization Celerion.
marcus evans Summits is pleased to announce Norwich Clinical Research Associates, proud Sponsor at the annual Evolution Summit, May 4-6, 2011 at the prestigious Westin Diplomat Resort & Spa, Hollywood, FL.
A series of webinars aimed at those working in the processing environment will take place during April, May and September 2011 as part of Malvern Instruments’ extensive web seminar program.
The firm Haupt Pharma Brackenheim GmbH is awarded 98 out of a possible 100 points in the certification audit of the International Food Standard.
With an increasing number of drug delivery devices, primarily auto injectors and pen injectors, under development and soon entering mass production, SHL Automation has been steadily working towards enhancing SHL’s in-house automated sub-assembly solutions. One related development program involves the re-engineering and streamlining of component assembly for a key auto injector project.
SHL is introducing its first “pre-configured” auto injector to the B2B market for leading biotechnology and pharmaceutical companies. Molly is an intuitive device featuring an ultra-compact design, simplified 2-step operation and a permanently hidden needle. Thanks to collaborative efforts of SHL teams in Sweden, Taiwan and the USA, key development/design work has already been standardized to accelerate speed-to-market for customers. The compact device utilizes state-of-the-art safety and ergonomic features, and is considered by many to be SHL’s next-generation breakthrough auto injector.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.